Qnovia, Inc.: Qnovia to Pursue UK Approval for Lead Asset QN-01 in Nicotine Replacement Therapy

Company plans to pursue UK authorization in parallel to approval in the U.S. Qnovia, Inc. ("Qnovia"), a pharma company developing inhaled therapeutics with an initial focus on nicotine replacement

Related Keywords

United Kingdom ,Kiki Patel ,Kostenloser Wertpapierhandel ,Mario Danek ,Richard Laermer ,Brian Quigley ,Gilmartin Group ,Qnovia Inc ,Regulatory Agency ,Respira Technologies Inc ,Blue Ledge Capital ,Respira Technologies ,Qnovia ,Ursue ,Approval ,Head ,Sset ,Nicotine ,Replacement ,Therapy ,